Engaging plasticity: Differentiation therapy in solid tumors

Cancer is a systemic heterogeneous disease that can undergo several rounds of latency and activation. Tumor progression evolves by increasing diversity, adaptation to signals from the microenvironment and escape mechanisms from therapy. These dynamic processes indicate necessity for cell plasticity....

Full description

Bibliographic Details
Main Authors: Neta Bar-Hai, Dana Ishay-Ronen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.944773/full
_version_ 1811321709739900928
author Neta Bar-Hai
Neta Bar-Hai
Dana Ishay-Ronen
Dana Ishay-Ronen
author_facet Neta Bar-Hai
Neta Bar-Hai
Dana Ishay-Ronen
Dana Ishay-Ronen
author_sort Neta Bar-Hai
collection DOAJ
description Cancer is a systemic heterogeneous disease that can undergo several rounds of latency and activation. Tumor progression evolves by increasing diversity, adaptation to signals from the microenvironment and escape mechanisms from therapy. These dynamic processes indicate necessity for cell plasticity. Epithelial-mesenchymal transition (EMT) plays a major role in facilitating cell plasticity in solid tumors by inducing dedifferentiation and cell type transitions. These two practices, plasticity and dedifferentiation enhance tumor heterogeneity creating a key challenge in cancer treatment. In this review we will explore cancer cell plasticity and elaborate treatment modalities that aspire to overcome such dynamic processes in solid tumors. We will further discuss the therapeutic potential of utilizing enhanced cell plasticity for differentiation therapy.
first_indexed 2024-04-13T13:21:20Z
format Article
id doaj.art-1e8205f0c7294ce58e706f6552f55fcb
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-13T13:21:20Z
publishDate 2022-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-1e8205f0c7294ce58e706f6552f55fcb2022-12-22T02:45:17ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-08-011310.3389/fphar.2022.944773944773Engaging plasticity: Differentiation therapy in solid tumorsNeta Bar-Hai0Neta Bar-Hai1Dana Ishay-Ronen2Dana Ishay-Ronen3Cancer Research Center, Oncology Institute, Chaim Sheba Medical Center, Tel-Hashomer, IsraelAffiliated with Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelCancer Research Center, Oncology Institute, Chaim Sheba Medical Center, Tel-Hashomer, IsraelAffiliated with Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelCancer is a systemic heterogeneous disease that can undergo several rounds of latency and activation. Tumor progression evolves by increasing diversity, adaptation to signals from the microenvironment and escape mechanisms from therapy. These dynamic processes indicate necessity for cell plasticity. Epithelial-mesenchymal transition (EMT) plays a major role in facilitating cell plasticity in solid tumors by inducing dedifferentiation and cell type transitions. These two practices, plasticity and dedifferentiation enhance tumor heterogeneity creating a key challenge in cancer treatment. In this review we will explore cancer cell plasticity and elaborate treatment modalities that aspire to overcome such dynamic processes in solid tumors. We will further discuss the therapeutic potential of utilizing enhanced cell plasticity for differentiation therapy.https://www.frontiersin.org/articles/10.3389/fphar.2022.944773/fullcancer cell plasticityEMTdifferentiation therapytrans-differentiationTGFb signalingsolid tumors
spellingShingle Neta Bar-Hai
Neta Bar-Hai
Dana Ishay-Ronen
Dana Ishay-Ronen
Engaging plasticity: Differentiation therapy in solid tumors
Frontiers in Pharmacology
cancer cell plasticity
EMT
differentiation therapy
trans-differentiation
TGFb signaling
solid tumors
title Engaging plasticity: Differentiation therapy in solid tumors
title_full Engaging plasticity: Differentiation therapy in solid tumors
title_fullStr Engaging plasticity: Differentiation therapy in solid tumors
title_full_unstemmed Engaging plasticity: Differentiation therapy in solid tumors
title_short Engaging plasticity: Differentiation therapy in solid tumors
title_sort engaging plasticity differentiation therapy in solid tumors
topic cancer cell plasticity
EMT
differentiation therapy
trans-differentiation
TGFb signaling
solid tumors
url https://www.frontiersin.org/articles/10.3389/fphar.2022.944773/full
work_keys_str_mv AT netabarhai engagingplasticitydifferentiationtherapyinsolidtumors
AT netabarhai engagingplasticitydifferentiationtherapyinsolidtumors
AT danaishayronen engagingplasticitydifferentiationtherapyinsolidtumors
AT danaishayronen engagingplasticitydifferentiationtherapyinsolidtumors